TREM-1 involvement in NSCLC progression was further demonstrated by the finding that TREM-1 engagement by an agonist mAb in macrophages increased NSCLC’s cell invasive ability, which was suppressed upon TREM-1 inhibition by shRNA [221]. Here, TREM1 is linked to non-small cell lung carcinoma.